| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
|
Circulation
|
2013
|
3.90
|
|
2
|
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.
|
Atherosclerosis
|
2004
|
3.55
|
|
3
|
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
|
Circulation
|
2009
|
3.28
|
|
4
|
The predictive value of different measures of obesity for incident cardiovascular events and mortality.
|
J Clin Endocrinol Metab
|
2010
|
3.12
|
|
5
|
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk.
|
J Clin Endocrinol Metab
|
2006
|
1.87
|
|
6
|
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.
|
Clin Res Cardiol
|
2011
|
1.58
|
|
7
|
Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study.
|
Cerebrovasc Dis
|
2010
|
1.55
|
|
8
|
Elevated risk profile of women in secondary prevention of coronary artery disease: a 6-year survey of 117,913 patients.
|
J Womens Health (Larchmt)
|
2009
|
1.53
|
|
9
|
Association of low ankle brachial index with high mortality in primary care.
|
Eur Heart J
|
2006
|
1.53
|
|
10
|
Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study.
|
Hum Psychopharmacol
|
2002
|
1.51
|
|
11
|
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.
|
Int J Cardiol
|
2012
|
1.48
|
|
12
|
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.
|
Am J Hypertens
|
2004
|
1.48
|
|
13
|
Systemic sclerosis - continuing progress in developing clinical measures of response.
|
J Rheumatol
|
2007
|
1.46
|
|
14
|
High prevalence and poor control of hypertension in primary care: cross-sectional study.
|
J Hypertens
|
2004
|
1.43
|
|
15
|
Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication.
|
J Hypertens
|
2011
|
1.42
|
|
16
|
Drug interactions with angiotensin receptor blockers.
|
Expert Opin Drug Saf
|
2005
|
1.41
|
|
17
|
Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nurses.
|
Vasc Med
|
2007
|
1.23
|
|
18
|
High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking.
|
J Clin Psychiatry
|
2003
|
1.17
|
|
19
|
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
|
Thorax
|
2013
|
1.14
|
|
20
|
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
|
Eur Heart J
|
2008
|
1.10
|
|
21
|
Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease.
|
BMC Public Health
|
2007
|
1.06
|
|
22
|
Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level.
|
Atherosclerosis
|
2005
|
0.96
|
|
23
|
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
|
J Rheumatol
|
2009
|
0.95
|
|
24
|
Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
|
Clin Res Cardiol
|
2009
|
0.94
|
|
25
|
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
|
Arthritis Rheum
|
2008
|
0.94
|
|
26
|
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs.
|
Int J Cardiol
|
2012
|
0.93
|
|
27
|
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group.
|
Ann Rheum Dis
|
2010
|
0.92
|
|
28
|
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
|
J Rheumatol
|
2009
|
0.91
|
|
29
|
Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study.
|
Int J Cardiol
|
2012
|
0.90
|
|
30
|
Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.
|
BMC Public Health
|
2009
|
0.87
|
|
31
|
Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.
|
Clin Endocrinol (Oxf)
|
2008
|
0.85
|
|
32
|
High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes.
|
Diabetes Care
|
2003
|
0.85
|
|
33
|
Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients.
|
PLoS One
|
2012
|
0.84
|
|
34
|
Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.
|
Int J Methods Psychiatr Res
|
2005
|
0.84
|
|
35
|
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011.
|
Int J Cardiol
|
2011
|
0.83
|
|
36
|
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients.
|
Blood Press
|
2004
|
0.83
|
|
37
|
"As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
|
Ann Clin Psychiatry
|
2002
|
0.82
|
|
38
|
Prognostic value of a low post-exercise ankle brachial index as assessed by primary care physicians.
|
Atherosclerosis
|
2010
|
0.81
|
|
39
|
Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study.
|
Clin Res Cardiol
|
2013
|
0.80
|
|
40
|
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care.
|
Curr Med Res Opin
|
2010
|
0.80
|
|
41
|
Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis.
|
Arzneimittelforschung
|
2003
|
0.80
|
|
42
|
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.
|
Arthritis Res Ther
|
2011
|
0.80
|
|
43
|
Relationship between lipid parameters and the presence of peripheral arterial disease in elderly patients.
|
Curr Med Res Opin
|
2004
|
0.80
|
|
44
|
Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men.
|
Steroids
|
2011
|
0.80
|
|
45
|
[Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)].
|
Med Klin (Munich)
|
2008
|
0.80
|
|
46
|
Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women.
|
Curr Med Res Opin
|
2009
|
0.79
|
|
47
|
Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.
|
Curr Med Res Opin
|
2008
|
0.79
|
|
48
|
Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
|
Clin Pharmacol Ther
|
2004
|
0.79
|
|
49
|
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
|
Clin Exp Rheumatol
|
2010
|
0.79
|
|
50
|
Gender differences in patients with atrial fibrillation.
|
Herzschrittmacherther Elektrophysiol
|
2013
|
0.79
|
|
51
|
[The use of guidelines in the primary care management of hypertension and diabetes].
|
Soz Praventivmed
|
2004
|
0.78
|
|
52
|
Frequency of albuminuria in primary care: a cross-sectional study.
|
Eur J Cardiovasc Prev Rehabil
|
2007
|
0.78
|
|
53
|
[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods].
|
Med Klin (Munich)
|
2010
|
0.78
|
|
54
|
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.
|
BMC Health Serv Res
|
2014
|
0.78
|
|
55
|
Management and outcomes of patients with reduced ejection fraction after acute myocardial infarction in cardiac rehabilitation centers.
|
Curr Med Res Opin
|
2014
|
0.77
|
|
56
|
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.
|
Eur J Endocrinol
|
2008
|
0.77
|
|
57
|
Ankle brachial index vs metabolic syndrome for risk prediction.
|
Lancet
|
2008
|
0.76
|
|
58
|
Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study.
|
Curr Med Res Opin
|
2011
|
0.76
|
|
59
|
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry.
|
J Clin Immunol
|
2012
|
0.76
|
|
60
|
EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome.
|
BMC Psychiatry
|
2013
|
0.76
|
|
61
|
Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers.
|
Clin Cardiol
|
2014
|
0.76
|
|
62
|
Development of Clinical Trial Assessments for the Study of Interstitial Lung Disease in Patients who have Connective Tissue Diseases-Methodological Considerations.
|
Curr Rheumatol Rev
|
2010
|
0.75
|
|
63
|
Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.
|
Vasc Health Risk Manag
|
2013
|
0.75
|
|
64
|
Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice.
|
Curr Med Res Opin
|
2012
|
0.75
|
|
65
|
[Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study].
|
Med Klin (Munich)
|
2009
|
0.75
|
|
66
|
Aims, design and methods of the Smoking and Nicotine Dependence Awareness and Screening (SNICAS) study.
|
Int J Methods Psychiatr Res
|
2003
|
0.75
|
|
67
|
Management of patients with atrial fibrillation by primary-care physicians in Germany: 1-year results of the ATRIUM registry.
|
Clin Cardiol
|
2014
|
0.75
|
|
68
|
[Importance of the ankle-brachial index (ABI) in the prevention of cardiovascular diseases. Ten questions and answers].
|
Herz
|
2007
|
0.75
|
|
69
|
Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy?
|
Chemotherapy
|
2003
|
0.75
|
|
70
|
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
|
J Rheumatol
|
2011
|
0.75
|
|
71
|
Effect of guideline orientation on the outcomes of peripheral arterial disease in primary care.
|
Curr Med Res Opin
|
2011
|
0.75
|
|
72
|
[Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?]
|
Dtsch Med Wochenschr
|
2017
|
0.75
|